We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Pfizer's Sutent for Kidney and Stomach Cancer
FDA Approves Pfizer's Sutent for Kidney and Stomach Cancer
February 3, 2006
The FDA has approved Pfizer’s new drug application (NDA) for Sutent, a highly anticipated treatment for patients with a rare type of stomach cancer and advanced kidney cancer.